Kåre Schultz, Teva CEO (Christopher Goodney/Bloomberg via Getty Images)

Te­va reach­es $523M agree­ment with New York in lat­est opi­oid-re­lat­ed set­tle­ment

Te­va has been work­ing on mak­ing head­way with its planned na­tion­al set­tle­ment over its role in the US opi­oid epi­dem­ic. And it has one less state to be fo­cused on.

Te­va ex­ecs con­firmed that a set­tle­ment was reached in New York, echo­ing an an­nounce­ment from New York At­tor­ney Gen­er­al Leti­tia James ear­li­er this week. The AG con­firmed that the state gets more than half a bil­lion dol­lars from the gener­ics gi­ant, end­ing the state’s lit­i­ga­tion against opi­oid man­u­fac­tur­ers and dis­trib­u­tors.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.